Spoken Alpha
QIAGEN N.V.
QIAGEN N.V is a Healthcare company operating in Diagnostics & Research with a $8.77B market cap.
Most recent earnings call: Q4 FY25 on Feb 5, 2026.
20 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from SEC 10-K filing, 2026-08-30.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for QGEN.
$ curl https://api.spokenalpha.com/v1/companies/QGENFAQ
Spoken Alpha indexes QGEN's earnings call transcripts at https://spokenalpha.com/companies/QGEN. Each call links to attributed speakers and parsed analyst Q&A. QIAGEN N.V.'s own investor relations page is at https://corporate.qiagen.com/investor-relations/overview/.
QIAGEN N.V. (QGEN) held its most recent earnings call on 2026-02-05, covering fiscal Q4 2025.
QIAGEN N.V. (QGEN) operates in the Healthcare sector (Diagnostics & Research industry).